Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
ISRG US​

Intuitive Surgical Inc(ISRG US)

$452.29+8.441.90%Ext:$452.29+0.000.00%(Market Closed · 23:59:33 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Intuitive Surgical Inc — Company Profile

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sector
Materials
Industry
Paper & Forest Products
Exchange
UQ
CEO
David J. Rosa
Headquarters
Sunnyvale, CA, US
IPO Date
Jun 16, 2000
Employees
17,021
Website
www.intuitive.com

Key Metrics

Price
$391.95
Market Cap
$138.47B
Revenue (TTM)
$2.89B
Net Income (TTM)
$818.10M
EPS (TTM)
2.32
P/E (TTM)
46.48
P/B (TTM)
7.57
Dividend Yield
0.00%
ROE (TTM)
4.70%
ROA (TTM)
4.08%
Operating Margin
30.87%
Beta
0.80

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Website
www.intuitive.com
Location
Sunnyvale, CA, US
Phone408 523 2100
Employees17,021
CEODavid J. Rosa
Sector
Materials
Industry
Paper & Forest Products
IPO DateJun 16, 2000

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(2.4K)

Expand
  • 144Widman Fredrik23 Oct
  • 144GUTHART GARY S23 Oct
  • 144BARRATT CRAIG H23 Oct
  • 144WADORS PATRICIA L23 Oct
  • 10-QQ3ended 30 Sept 202621 Oct
  • 8-KResults of Operations and Financial Condition20 Oct
  • 4WADORS PATRICIA L13 Oct
  • 4LOEB GARY13 Oct
  • 4Widman Fredrik16 Sep
  • 144Widman Fredrik15 Sep
  • 4Brosius Mark11 Sep
  • 4Brosius Mark9 Sep
  • 144Brosius Mark8 Sep
  • 4Brosius Mark21 Aug
  • 4Brosius Mark19 Aug
  • 4GUTHART GARY S12 Aug
  • 4Ladd Amy L11 Aug
  • 144GUTHART GARY S11 Aug
  • 4LOEB GARY10 Aug
  • 144Ladd Amy L10 Aug

News

  • New Strong Buy Stocks for October 23rd23 Oct
  • Intuitive Surgical, Inc. $ISRG Shares Sold by Cadinha & Co. LLC23 Oct
  • Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought22 Oct
  • Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story22 Oct
  • Intuitive Surgical (NASDAQ:ISRG) Given “Buy” Rating at BTIG Research22 Oct
  • 2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG21 Oct
  • ISRG Q3 Earnings Call Highlights Pricing and Growth Strategy21 Oct
  • Intuitive Surgical: 3 Key Takeaways for Long-Term Investors21 Oct
  • Intuitive Surgical Q3: The Best Way To Grow May Be To Charge Less21 Oct
  • Intuitive Surgical's Q3 Earnings Beat Estimates on Strong System Sales21 Oct
  • Intuitive Surgical, Inc. (ISRG) Crossed Above the 200-Day Moving Average: What That Means for Investors21 Oct
  • These Analysts Revise Their Forecasts On Intuitive Surgical After Q3 Results21 Oct
  • Here Are Wednesday’s Top Wall Street Analyst Research Calls: Applied Digital, Chipotle Mexican Grill, Cirrus Logic, Costco, Digital Realty Trust, Intuitive Surgical, Netflix, Robinhood Markets, Zscaler, and More21 Oct
  • Intuitive Surgical Stock Falls Despite da Vinci 5 Placements Jump21 Oct
  • Intuitive Surgical Inc (ISRG) (Q3 2026) Earnings Call Highlights: Revenue Jumps 22% to $3 Billion as Procedure Growth and Record Placements Offset Pricing Headwinds21 Oct
  • Intuitive Surgical, Inc. (ISRG) Q3 2026 Earnings Call Transcript20 Oct
  • What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Call20 Oct
  • Intuitive Surgical (ISRG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates20 Oct
  • Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates20 Oct
  • Intuitive Surgical Stock Slides Despite Earnings Beat as Company Discloses Settlement20 Oct

Mentions in Filings

  • … ory of investment experience as well as his experience with start-ups and technology companies. **Dr. Catherine Mohr** has served as a member of our board of directors since December 2021. Dr. Mohr has been with <strong>Intuitive Surgical, Inc.</strong>, a developer and manufacturer of surgical robotic products designed to improve clinical outcomes of patients, since May 2016, where she has served in various executive roles, including as vice president, strategy …
    ZincFive, Inc.Intuitive Surgical Inc·S-4/A - Registration statement (business combination, amendment)·Q4 26·21 Oct
  • … 023, where he served in various senior-level sales positions, including most recently as Vice President Sales, Americas APAC from July 2022 to July 2023. Prior to that he served in various sales-related positions at <strong>Intuitive Surgical</strong>, Mpathy Medical, Cook Medical and Eli Lilly & Company. Mr. Miele holds a B.S. in Finance and Marketing from Northeastern University. 17 --- TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS Introduction T …
    ACCURAY INCIntuitive Surgical Inc·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … elman brings extensive experience in advising and investing in emerging growth companies in the technology, media, medical device and biotech sectors. Mr. Adelman was the lead banker in Computer Motion’s merger with <strong>Intuitive Surgical</strong> and was a member of the board of directors of Pharmacyclics prior to its acquisition by Abbvie for over $20 billion. Currently, Mr. Adelman serves as a member of the board of directors of Trio-Tech International, a …
    FullPAC, Inc.Intuitive Surgical Inc·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·9 Oct
  • … EC under the Exchange Act can be located by reference to its SEC file number: 000-51222, or its CIK Code: 0001093557. Its common stock is listed on the Nasdaq Global Select Market under the ticker symbol “DXCM.” <strong>Intuitive Surgical, Inc.</strong> develops, manufactures, and markets surgery products. Information filed by the company with the SEC under the Exchange Act can be located by reference to its SEC file number: 000-30713, or its CIK Code: 000103526 …
    BANK OF MONTREAL /CAN/Intuitive Surgical Inc·FWP - ELN 6351·Q4 26·6 Oct
  • … ine Somashekhar SP, MD, Board Member • Robotic Surgeon • Global Director, Aster International Institute of Oncology Frederic Moll, MD, Vice-Chairman • Former Chief Development Officer, J&J Medical Devices • Founder, <strong>Intuitive Surgical</strong>, Hansen Medical, Auris Health • Co-Founder & Partner, Sonder Capital Management • Board Member, PROCEPT BioRobotics, Neptune Medical, Moon Surgical • Former Board Member, Shockwave Medical, Restoration Robotics, Int …
    SS Innovations International, Inc.Intuitive Surgical Inc·EX-99.1 - 8-K - Regulation FD Disclosure·Q4 26·5 Oct
  • … Inc. | 116.160 | 13,706.88 | | | | **Energy - 4.01%** | | | | | 244 | Baker Hughes Company - CL A | 55.370 | 13,510.28 | | | | **Health Care - 7.95%** | | | | | 160 | DexCom, Inc. | 83.470 | 13,355.20 | | | 32 | <strong>Intuitive Surgical, Inc.</strong> | 420.240 | 13,447.68 | | | | **Industrials - 4.03%** | | | | | 65 | Cintas Corporation | 208.630 | 13,560.95 | | | | **Information Technology - 47.91%** | | | | | 24 | Advanced Micro Devices, Inc. | 570.820 | 13 …
    Invesco Unit Trusts Series 2502Intuitive Surgical Inc·487 - VKUT 2502·Q4 26·15 Oct

Key Stats

Trading

Px/Chg 1D$391.95 / -2.32%
Avg Volume2.12M
Beta0.80
Mkt Cap138.47B
FD Mkt Cap132.21B

Float

Shrs Out/Float353.28M / 351.21M
Short Float0.02%
Days to Cover2.69
Stock Repurchased$1.12B

Current Valuation

EV129.84B
EV/EBITDA32.28
EV/Sales12.90
P/B7.57
P/S13.09
FCF Yield0.58%
ROE4.70%
ROA4.08%
Current Ratio6.03

Estimates

P/E46.48
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgApr '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings119.4280.3272.7973.21201.51169.25
Price / Sales31.9117.0718.3720.3655.8847.87
Price / Book Value9.279.629.8310.358.997.57
Price / Free Cash Flow161.29110.81174.58130.43219.40171.24
ENTERPRISE VALUE METRICS
Enterprise Value137,643.6104,690.8128,207.3168,262.9157,215.3129,841.8
Enterprise Value / Sales30.9416.8318.0020.1554.8544.89
Enterprise Value / EBITDA91.8753.8859.1159.86133.63152.84
Enterprise Value / EBIT75.0266.3872.5671.63164.520.00

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue15.2%5,710.16,222.27,124.18,352.110,064.7
Gross Income13.8%3,958.54,196.04,729.55,634.26,642.3
EBITDA17%2,131.21,942.92,169.02,810.93,988.5
EBIT16.1%1,821.01,577.11,766.82,348.93,311.4
Net Income13.8%1,704.61,322.31,798.02,322.62,856.0
EPS (Diluted)14%4.663.655.036.427.87
BALANCE SHEET
Cash & ST Inv8.8%4,230.94,117.95,223.24,013.35,934.9
Total Assets11.1%13,555.012,974.015,441.518,838.620,631.2
Total Liabilities13.8%1,603.51,861.42,044.22,309.02,689.5
Total Shareholder Equity10.5%11,951.511,041.913,307.616,433.717,824.0
CASH FLOW
Net Operating Cash Flow9.7%2,089.41,490.81,813.82,415.03,030.5
Cap Ex11.2%-353.5-532.4-1,064.2-1,111.2-539.8
Free Cash Flow9.4%1,735.9958.4749.61,303.82,490.7

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)452.29
Basic Shares353.28
Market Cap159,784.1
Diluted Shares351.60
Fully Diluted Shares Outstanding351.60
Fully Diluted Market Cap159,025.2
+Consolidated Debt-
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-6,800.4
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value152,983.7

Segment data

Revenue

by Products and services

  • Instruments And Accessories60%
  • Systems25%
  • Services16%

Revenue

by Geography

  • Geographic Distribution, Domestic68%
  • Geographic Distribution, Foreign32%

Related companies

Amgen Inc

AMGN US

Gilead Sciences, Inc.

GILD US

Moderna, Inc.

MRNA US

Argenx Se

ARGX US

Edwards Lifesciences Corporation

EW US

Revolution Medicines, Inc.

RVMD US

Biogen Inc.

BIIB US

BioNTech SE

BNTX US

STERIS plc

STE US

Nordson Corp

NDSN US

Tyson Foods, Inc.

TSN US

Zimmer Biomet Holdings Inc.

ZBH US